Search

everythinglearnresearchcommunity

for

Search:↓

Over half of young people in Saudi Arabia experience early gray hair, linked to factors like smoking, stress, and family history.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

New regenerative therapies show promise for treating hair loss.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Male pattern baldness does not cause an increased risk of prostate cancer.

The Shen Bai Hair Growing Decoction may help treat hair loss by promoting hair growth and reducing inflammation.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Microneedle-assisted therapy with human basic fibroblast growth factor significantly regrew hair in patients with hair loss.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

A hat with sensors can measure scalp moisture well, helping with hair care.

The research found new potential mechanisms in mouse hair growth by studying RNA interactions.

Male pattern baldness is a common hair loss in men caused by genetics and hormones, with treatments including drugs, hair transplants, and hair loss products.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Thermal spring waters and their microbes could be good for skin health and treating some skin conditions in skincare products.

Latanoprost-loaded nanotransfersomes could help treat hair loss by promoting hair growth.

Combining micro-needling, LED therapy, and growth factors with Finasteride® significantly improves hair growth.

The serum increased hair density and was well-tolerated, but didn't affect hair thickness or shedding.

Witch hazel-based hair products improved scalp irritation and were well-tolerated.

Many people with hair loss, especially those with telogen effluvium and alopecia areata, often have a sensitive scalp.

The scalp serum reduced scalp discomfort and symptoms without affecting skin moisture loss.

Sensitive scalp has higher pH, more redness, abnormal sebum, and altered bacterial makeup.

New 5% minoxidil solution improves scalp hydration, reduces redness, and may be safer for sensitive users.

Air pollution can cause hair loss, and using antioxidants, special shampoos, and coconut oil can improve scalp health and hair density.